Lotus Bio Technology Development Stock Earnings Per Share
| LBTD Stock | USD 0.01 0.00 0.00% |
Lotus Bio Technology Development fundamentals help investors to digest information that contributes to Lotus Bio's financial success or failures. It also enables traders to predict the movement of Lotus Pink Sheet. The fundamental analysis module provides a way to measure Lotus Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lotus Bio pink sheet.
Lotus |
Lotus Bio Technology Development Company Earnings Per Share Analysis
Lotus Bio's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Lotus Bio Technology Development has an Earnings Per Share of 0.0 times. This is 100.0% lower than that of the Media (discontinued effective close of September 28, 2018) sector and 100.0% lower than that of the Consumer Discretionary industry. The earnings per share for all United States stocks is 100.0% higher than that of the company.
Lotus Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lotus Bio's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Lotus Bio could also be used in its relative valuation, which is a method of valuing Lotus Bio by comparing valuation metrics of similar companies.Lotus Bio is currently under evaluation in earnings per share category among its peers.
Lotus Fundamentals
| Return On Asset | -4.21 | |||
| Current Valuation | 31.31 M | |||
| Shares Outstanding | 782.77 M | |||
| Shares Owned By Insiders | 60.40 % | |||
| Price To Earning | (1.71) X | |||
| Net Income | (19.55 K) | |||
| Cash And Equivalents | 1 | |||
| Total Debt | 16.68 K | |||
| Cash Flow From Operations | (17.75 K) | |||
| Beta | -1.44 | |||
| Market Capitalization | 13.78 M | |||
| Total Asset | 5.46 K | |||
| Retained Earnings | (931 K) | |||
| Working Capital | (68 K) | |||
| Current Liabilities | 68 K | |||
| Net Asset | 5.46 K |
About Lotus Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lotus Bio Technology Development's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Bio Technology Development based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Lotus Pink Sheet
Lotus Bio financial ratios help investors to determine whether Lotus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lotus with respect to the benefits of owning Lotus Bio security.